Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)
Status:
Completed
Trial end date:
2019-11-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether in patients with early type 2 diabetes,a
short-term intensive metabolic intervention comprising of sitagliptin, metformin, basal
insulin glargine and lifestyle approaches will be superior to standard diabetes therapy in
achieving sustained diabetes remission.